Inozyme Pharma is now a wholly owned subsidiary of BioMarin Pharmaceutical Inc. BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. To learn more, please visit www.biomarin.com.
General Inquiries: media@biomarin.com | +1 (415) 506-6700
Medical Information Inquiries: medicalinformation@inozyme.com